{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T10:04:31Z","timestamp":1783332271164,"version":"3.54.6"},"reference-count":24,"publisher":"Society of Nuclear Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.2967\/jnumed.121.262928","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T22:30:15Z","timestamp":1646951415000},"page":"1509-1514","source":"Crossref","is-referenced-by-count":27,"title":["Heterogeneity of SSTR2 Expression Assessed by <sup>68<\/sup>Ga-DOTATOC PET\/CT Using Coefficient of Variation in Patients with Neuroendocrine Tumors"],"prefix":"10.2967","volume":"63","author":[{"given":"Rosa","family":"Fonti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Panico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pellegrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pulcrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa Alessia","family":"Vastarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin Hakkak Moghadam","family":"Torbati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovannella","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabino","family":"De Placido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Del Vecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"2022100315301341000_63.10.1509.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.03.304"},{"key":"2022100315301341000_63.10.1509.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607427"},{"key":"2022100315301341000_63.10.1509.3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11864-019-0677-7","article-title":"Peptide receptor radiotherapy: current approaches and future directions","volume":"20","author":"Kong","year":"2019","journal-title":"Curr Treat Options Oncol."},{"key":"2022100315301341000_63.10.1509.4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1385\/ENDO:20:3:255","article-title":"Somatostatin and somatostatin receptor physiology","volume":"20","author":"Barnett","year":"2003","journal-title":"Endocrine."},{"key":"2022100315301341000_63.10.1509.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2004.02402.x"},{"key":"2022100315301341000_63.10.1509.6","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-003-1184-3"},{"key":"2022100315301341000_63.10.1509.7","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/MPA.0000000000000700","article-title":"Association between somatostatin receptor expression and clinical outcomes in neuroendocrine tumors","volume":"45","author":"Qian","year":"2016","journal-title":"Pancreas."},{"key":"2022100315301341000_63.10.1509.8","doi-asserted-by":"crossref","first-page":"679000","DOI":"10.3389\/fendo.2021.679000","article-title":"Role of somatostatin receptor in pancreatic neuroendocrine tumor development, diagnosis, and therapy","volume":"12","author":"Hu","year":"2021","journal-title":"Front Endocrinol (Lausanne)."},{"key":"2022100315301341000_63.10.1509.9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000497355","article-title":"The tumor microenvironment in neuroendocrine tumors: biology and therapeutic implications","volume":"109","author":"Cives","year":"2019","journal-title":"Neuroendocrinology."},{"key":"2022100315301341000_63.10.1509.10","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-020-09607-z"},{"key":"2022100315301341000_63.10.1509.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.165092"},{"key":"2022100315301341000_63.10.1509.12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41467-020-20308-8","article-title":"Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy","volume":"12","author":"Lechner","year":"2021","journal-title":"Nat Commun."},{"key":"2022100315301341000_63.10.1509.13","doi-asserted-by":"crossref","first-page":"7039","DOI":"10.18632\/oncotarget.12402","article-title":"Survival prediction in patients undergoing radionuclide therapy based on intratumoral somatostatin-receptor heterogeneity","volume":"8","author":"Werner","year":"2017","journal-title":"Oncotarget."},{"key":"2022100315301341000_63.10.1509.14","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/MNM.0000000000001231","article-title":"Could the skewness and kurtosis texture parameters of lesions obtained from pretreatment Ga-68 DOTA-TATE PET\/CT images predict receptor radionuclide therapy response in patients with gastroenteropancreatic neuroendocrine tumors?","volume":"41","author":"\u00d6nner","year":"2020","journal-title":"Nucl Med Commun."},{"key":"2022100315301341000_63.10.1509.15","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12885-020-06836-y","article-title":"Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from 68Ga-DOTATOC PET\/MRI with simultaneous acquisition of apparent diffusion coefficient","volume":"20","author":"Weber","year":"2020","journal-title":"BMC Cancer."},{"key":"2022100315301341000_63.10.1509.16","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/MNM.0000000000001236","article-title":"Dual tracer 68Ga-DOTATOC and 18F-FDG PET\/computed tomography radiomics in pancreatic neuroendocrine neoplasms: an endearing tool for preoperative risk assessment","volume":"41","author":"Mapelli","year":"2020","journal-title":"Nucl Med Commun."},{"key":"2022100315301341000_63.10.1509.17","doi-asserted-by":"crossref","first-page":"601853","DOI":"10.3389\/fmed.2020.601853","article-title":"68Ga-DOTATOC-PET\/CT-based radiomic analysis and PRRT outcome: a preliminary evaluation based on an exploratory radiomic analysis on two patients","volume":"7","author":"Liberini","year":"2021","journal-title":"Front Med (Lausanne)."},{"key":"2022100315301341000_63.10.1509.18","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-0125"},{"key":"2022100315301341000_63.10.1509.19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.106500"},{"key":"2022100315301341000_63.10.1509.20","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s12149-019-01407-z","article-title":"Total metabolic tumor volume by 18F-FDG PET\/CT for the prediction of outcome in patients with non-small cell lung cancer","volume":"33","author":"Pellegrino","year":"2019","journal-title":"Ann Nucl Med."},{"key":"2022100315301341000_63.10.1509.21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/j.seminoncol.2019.07.001","article-title":"PET\/CT in radiation oncology","volume":"46","author":"Fonti","year":"2019","journal-title":"Semin Oncol."},{"key":"2022100315301341000_63.10.1509.22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40658-021-00367-6","article-title":"Impact of segmentation and discretization on radiomic features in 68Ga-DOTA-TOC PET\/CT images of neuroendocrine tumor","volume":"8","author":"Liberini","year":"2021","journal-title":"EJNMMI Phys."},{"key":"2022100315301341000_63.10.1509.23","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1007\/s00259-021-05338-8","article-title":"Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance","volume":"48","author":"Bezzi","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2022100315301341000_63.10.1509.24","doi-asserted-by":"crossref","unstructured":"Saleh M Bhosale PR Yano M . New frontiers in imaging including radiomics updates for pancreatic neuroendocrine neoplasms. Abdom Radiol (NY). October 23, 2020 [Epub ahead of print].","DOI":"10.1007\/s00261-020-02833-8"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.121.262928","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T22:36:04Z","timestamp":1664836564000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.121.262928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":24,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10,3]]},"published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.2967\/jnumed.121.262928"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.121.262928","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]}}}